Market Overview

Benzinga's Top Pre-Market Gainers

Related TRGT
Catalyst Biosciences Announces Positive Results From a Phase 1 Clinical Trial of Its Next Generation Coagulation Factor VIIa in Patients With Hemophilia A or B and Preclinical Results
Targacept and Catalyst Biosciences Amend Definitive Merger Agreement
Related VVUS
Earnings Scheduled For March 9, 2016
Vivus And Oreixigen Have Too Many Problems For Investors, RBC's Simeonidis Claims

Targacept (NASDAQ: TRGT) soared 5.34% to $4.54 in the pre-market trading. Targacept reported top-line results from a Phase 2 trial of TC-5619 in adults with inattentive-predominant attention deficit/hyperactivity disorder.

VIVUS (NASDAQ: VVUS) surged 3.58% to $23.75 in the pre-market session. VIVUS announced the US market availability of Qsymia™.

Vodafone Group Public Limited Company (NASDAQ: VOD) added 1.42% to $28.65 in the pre-market session. Vodafone has a dividend yield of 7%.

ARM Holdings plc (NASDAQ: ARMH) moved up 0.98% to $28.79 in the pre-market session. ARM Holdings' trailing-twelve-month operating margin is 36.82%.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers


Related Articles (ARMH + TRGT)

View Comments and Join the Discussion!